Skip to main content
← Back to companies
Bicara Therapeutics logo

Bicara Therapeutics

0 open4 filled
Cambridge, Massachusetts, United StatesFounded 202058+ employeesGrowth raisedGrowthBCAX
Last round: post ipo equity · $150M · Feb 2026(4 rounds total)
Founded by Claire Mazumdar
Backed by(19 investors)
The Rise FundBraidwellRA Capital ManagementBioconRed Tree Venture CapitalTPGF-PrimeJanus Henderson InvestorsPremji InvestPiper Heartland Healthcare CapitalBioqube VenturesOmega FundsEight Roads VenturesDeerfield Management

Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.

Ready to start your space career at Bicara Therapeutics?

Shipping like we're funded. We're not. No affiliation.

Sequoia logo
Y Combinator logo
Founders Fund logo
a16z logo